108 related articles for article (PubMed ID: 3135966)
21. [The role of delta agent in particularly severe acute hepatitis B and non-A, non-B hepatitis in HBsAg carriers].
Nardi G; Ragni MC; Balboni E; Zanchetta N; Cambera G
Boll Ist Sieroter Milan; 1985; 64(5):371-5. PubMed ID: 3937544
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to hepatitis delta virus in intravenous drug addicts and male homosexuals in Spain.
León P; López JA; Contreras G; Echevarría JM
Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):533-5. PubMed ID: 3141166
[TBL] [Abstract][Full Text] [Related]
23. Clinical and epidemiological significance of hepatitis delta virus (HDV) infection in chronic HBV carriers in Portugal.
Ramalho F; Carvalho G; Bonino F; Baptista A; de Moura MC
Prog Clin Biol Res; 1987; 234():409-17. PubMed ID: 3628400
[TBL] [Abstract][Full Text] [Related]
24. Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador.
Ratnam S; Head CB; Butler RW
CMAJ; 1986 Apr; 134(8):905-7. PubMed ID: 3955485
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of anti-delta antibodies in pregnant women in Bandung, Indonesia.
Vranckx R; Reniers J; Alisjahbana A; Ngantung W; Sugita E; Meheus A
Trop Geogr Med; 1988 Jan; 40(1):17-9. PubMed ID: 3381311
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt.
el Zayadi A; Ponzetto A; Selim O; Forzani B; Lavarini C; Rizzetto M
Hepatogastroenterology; 1988 Dec; 35(6):313-5. PubMed ID: 3265126
[TBL] [Abstract][Full Text] [Related]
27. [Investigation of anticardiolipin antibodies in chronic hepatitis B infection together with total anti-delta positivity].
Meşe S; Ozekinci T; Atmaca S; Arikan E; Akin D
Mikrobiyol Bul; 2008 Jul; 42(3):483-7. PubMed ID: 18822893
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiology of hepatitis D virus infection].
Joller-Jemelka HI; Guggi T; Grob PJ
Schweiz Med Wochenschr; 1985 Nov; 115(47):1679-84. PubMed ID: 4081699
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence of hepatitis D in a population of Northeast Mexico and its relationship with other viruses].
Muñoz Espinosa LE; Ibarra Salas MJ
Rev Gastroenterol Mex; 1997; 62(4):246-9. PubMed ID: 9580232
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of hepatitis D virus infection: changes in the last 14 years.
Navascués CA; Rodríguez M; Sotorrío NG; Sala P; Linares A; Suárez A; Rodrigo L
Am J Gastroenterol; 1995 Nov; 90(11):1981-4. PubMed ID: 7485005
[TBL] [Abstract][Full Text] [Related]
31. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
[TBL] [Abstract][Full Text] [Related]
32. Determination of hepatitis delta virus (HDV)-RNA in asymptomatic cases of HDV infection.
Sakugawa H; Nakasone H; Kawakami Y; Adaniya H; Mizushima T; Nakayoshi T; Kinjo F; Saito A; Zukeran H; Miyagi Y; Yakabi S; Taira M; Kinoshita M; Yamakawa Y
Am J Gastroenterol; 1997 Dec; 92(12):2232-6. PubMed ID: 9399760
[TBL] [Abstract][Full Text] [Related]
33. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
35. Delta virus infection in Jerusalem.
Schuger L; Bonino F; Mushahwar IK; Ron N; Shouval D
Isr J Med Sci; 1988 Mar; 24(3):156-9. PubMed ID: 3286578
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Zukeran H
J Med Virol; 2001 Nov; 65(3):478-84. PubMed ID: 11596082
[TBL] [Abstract][Full Text] [Related]
37. [The prevalence and clinical characteristics of hepatitis-delta infection in Korea].
Jeong SH; Kim JM; Ahn HJ; Park MJ; Paik KH; Choi W; Kim J; Han CJ; Kim YC; Lee JO; Hong YJ; Park HY; Jeong HH; Yoon MY; Lee M; Lee KH
Korean J Hepatol; 2005 Mar; 11(1):43-50. PubMed ID: 15788884
[TBL] [Abstract][Full Text] [Related]
38. The association of hepatitis delta virus and hepatitis B virus in parenteral drug abusers. 1971 to 1972 and 1986 to 1987.
Lange WR; Cone EJ; Snyder FR
Arch Intern Med; 1990 Feb; 150(2):365-8. PubMed ID: 2302011
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of anti-delta antibodies in selected populations of HBsAg carriers in the Białystok region, Poland.
Boroń P; Boroń-Kaczmarska A; Bobrowska E; Kamińska H; Lapiński W
Prog Clin Biol Res; 1987; 234():427. PubMed ID: 3628403
[No Abstract] [Full Text] [Related]
40. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
